GCA
CHE icon

Gideon Capital Advisors’s Chemed CHE Stock Holding History

Gideon Capital Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-852
Closed -$273K – 293
2019
Q1 		$273K Buy
+852
New +$262K 0.1% 294
2018
Q2 		– Sell
-2,104
Closed -$574K – 379
2018
Q1 		$574K Buy
+2,104
New +$557K 0.36% 94

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Gideon Capital Advisors's CHE Position: Q2 2019 in Review

Gideon Capital Advisors sold out of Chemed (CHE) in Q2 2019, closing a stake of 852 shares — an estimated $273K sold.

Gideon Capital Advisors first reported a position in CHE in Q1 2018 and held it in 2 quarters. The position peaked at $574K in Q1 2018. 370 funds tracked by Wall St. Rank hold CHE as of Q2 2019.

  • Gideon Capital Advisors reported no remaining Chemed position as of Q2 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 852 Chemed shares in Q2 2019, an estimated $273K.
  • Gideon Capital Advisors first reported a position in Chemed in Q1 2018 and held it in 2 quarters.
  • Gideon Capital Advisors's Chemed position peaked at $574K in Q1 2018.
  • 370 funds tracked by Wall St. Rank held Chemed as of Q2 2019.

Based on Gideon Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.